Thus, modulation of SPARC production may have potential implications for postinfarction healing [40], and decorin has a protective role in several cardiac diseases, including atherosclerosis, hypertrophy, and myocardial infarction [41]. The gene discussed is DCN; the disease is cardiac hypertrophy.